Deborah E. Collyar

5.6k citations
81 papers · 4.0k · 3 hit papers · h-index 25

Impact in

    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
  • Oncology top 2%
    • HER2/EGFR in Cancer Research
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis

Papers in

Deborah E. Collyar

75 papers receiving 3.8k citations

Deborah E. Collyar's Hit Papers

Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision 2024 · 114 citations
1140+4+8Years since publication250500750

Peers

Deborah E. Collyar
Comparison fields: 5 of 121
  • Cancer Research 1.7k
  • Oncology 1.5k
  • Genetics 568
  • Pathology and Forensic Medicine 297
  • Pulmonary and Respiratory Medicine 453
Replace Begoña Bermejo with:
Begoña Bermejo Spain
Ann Marie Swart United Kingdom
Della Makower United States
Roman Gulati United States
Abenaa M. Brewster United States
Rachel A. Freedman United States
Peter Vuylsteke Belgium
Byeong‐Woo Park South Korea
Louis R. Bégin Canada
Veronique N. Trillet-Lenoir France
Deborah E. Collyar relative to Begoña Bermejo Spain Begoña Bermejo's profile →
Citations per field
00.5×1.5×2.0×
Begoña Bermejo · 1×
Citations per year

Countries citing papers authored by Deborah E. Collyar

Since Specialization
Citations

This map shows the geographic impact of Deborah E. Collyar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah E. Collyar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah E. Collyar more than expected).

Fields of papers citing papers by Deborah E. Collyar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah E. Collyar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah E. Collyar. The network helps show where Deborah E. Collyar may publish in the future.

Co-authors

The 25 scholars most cited alongside Deborah E. Collyar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Deborah E. Collyar Line = papers co-authored together Deborah E. Collyar links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
Hit paper breakdown →
2014800
2
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Hit paper breakdown →
2016655
3 2017240
4 2009237
5 2019234
6 2019172
7 2002164
8 1999134
9 2017127
10
Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision
Hit paper breakdown →
2024114
11 201481
12 201775
13 201370
14 201069
15 200462
16 201457
17 202255
18 201743
19 202434
20 202233

About Deborah E. Collyar

Deborah E. Collyar is a scholar working on Cancer Research, Public Health, Environmental and Occupational Health, Oncology, Economics and Econometrics and Genetics, having authored 81 papers that have together received 4.0k indexed citations. Recurring topics across this work include Ethics in Clinical Research (20 papers), Breast Cancer Treatment Studies (13 papers), Cancer Genomics and Diagnostics (11 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers), Biomedical Ethics and Regulation (6 papers), BRCA gene mutations in cancer (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Economic and Financial Impacts of Cancer (5 papers). The work is most often cited by research in Cancer Research (1.7k citations), Oncology (1.5k citations), Genetics (568 citations), Pathology and Forensic Medicine (297 citations) and Pulmonary and Respiratory Medicine (453 citations). Deborah E. Collyar has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Catherine H. Van Poznak, Nofisat Ismaila, Nicole M. Kuderer, Minetta C. Liu, Robert C. Bast, Fabrice André, Eric P. Winer, Robert Gary Mennel, Lyndsay N. Harris and Rowan T. Chlebowski. Their work appears in journals such as Clinical Infectious Diseases, Journal of Clinical Oncology, Clinical Cancer Research, Cancer and Open Forum Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact